Moderna, Inc. - COMMON STOCK (MRNA)

Historical Holders from Q4 2018 to Q3 2025

Symbol
MRNA on Nasdaq
CUSIP
60770K107
Type / Class
Equity / COMMON STOCK
Shares outstanding
385M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
275M
Holdings value
$7.09B
% of all portfolios
0.005%
Grand Portfolio weight change
-0.001%
Number of holders
619
Number of buys
256
Number of sells
-313
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Moderna, Inc. - COMMON STOCK (MRNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 6.5% -36% $679M -$379M 24.9M -35.8% BAILLIE GIFFORD & CO Mar 31, 2025
FMR LLC 3.2% -38.3% $318M -$228M 12.3M -41.8% FMR LLC Sep 30, 2025

Institutional Holders of Moderna, Inc. - COMMON STOCK (MRNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 275M $7.09B -$452M $25.83 619
2025 Q2 291M $8.04B +$363M $27.59 661
2025 Q1 279M $7.9B -$59.3M $28.35 675
2024 Q4 277M $11.5B +$499M $41.58 722
2024 Q3 257M $17.1B -$821M $66.83 765
2024 Q2 262M $31.1B +$414M $118.75 937
2024 Q1 259M $27.6B +$305M $106.56 880
2023 Q4 257M $25.5B +$1.29B $99.45 858
2023 Q3 243M $25.1B -$694M $103.29 867
2023 Q2 246M $29.9B -$274M $121.50 934
2023 Q1 249M $38.2B +$237M $153.58 993
2022 Q4 248M $44.5B +$449M $179.62 1,043
2022 Q3 246M $29.1B +$164M $118.25 877
2022 Q2 244M $34.9B -$467M $142.85 956
2022 Q1 248M $42.7B +$220M $172.26 983
2021 Q4 246M $62.4B -$17.2M $253.98 1,081
2021 Q3 225M $86.6B +$6.72B $384.86 1,120
2021 Q2 208M $48.8B +$5.17B $234.98 883
2021 Q1 188M $24.6B +$2.91B $130.95 754
2020 Q4 169M $17.6B -$534M $104.47 698
2020 Q3 205M $14.5B -$1B $70.75 547
2020 Q2 219M $14.1B +$1.61B $64.21 484
2020 Q1 196M $5.86B +$638M $29.95 287
2019 Q4 174M $3.41B +$268M $19.56 158
2019 Q3 110M $1.75B +$415M $15.92 133
2019 Q2 84.5M $1.24B +$117M $14.64 129
2019 Q1 79.5M $1.6B +$101M $20.35 103
2018 Q4 134M $2.02B +$2.02B $15.27 75